Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

The Effects of Vitamin D on the Breast Cancer Tumor Microenvironment

Source: Article title. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Review / evidence synthesis.

Review / evidence synthesis

Reviews existing research; the exact review methods need further assessment.

Meta-analysis unclear · Blinding not applicable to this review · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Publisher article type: review-article

Source: Publisher publication metadata.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

The Effects of Vitamin D on the Breast Cancer Tumor Microenvironment

Review / evidence synthesis · Cancers · 2025

Original publication title

The Effects of Vitamin D on the Breast Cancer Tumor Microenvironment

Balquees Kanwal; Syeda Saba Shah; Farzana Shaheen; Mekonnen Sisay Shiferaw; Deepanshu Maurya; Yujie Li; Saranya Pounraj; Zaklina Kovacevic

© 2025 by the authors.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Simple Summary

Breast cancer (BC) develops within a complex tumor microenvironment (TME) consisting of cancer-associated fibroblasts, adipocytes, immune cells, cancer stem cells, and the extracellular matrix, all of which play a crucial role in tumor progression and metastasis. Vitamin D (VD) is widely recognized for its protective effects against BC, due to its ability to regulate the cell cycle, promote apoptosis, inhibit angiogenesis, and suppress metastasis. While the anti-cancer properties of VD have been extensively studied, its specific role within the BC TME remains underexplored.

This review highlights VD’s regulatory influence on various TME components, underscoring its potential to reshape the TME and enhance BC treatment strategies.

Abstract

The intricate and diverse TME within breast cancer (BC) comprises a complex amalgamation of cell populations, encompassing immune cells, cancer-associated fibroblasts, cancer stem cells and the extracellular matrix. These constituents have profound influence over tumor progression and metastasis. Vitamin D (VD) is increasingly recognized as a multifunctional hormone, with strong clinical and epidemiological evidence supporting its protective role against cancer, particularly BC. Although its anti-neoplastic effects in BC have been widely studied, few investigations have thoroughly explored its influence within the tumor microenvironment (TME).

This review seeks to address that gap by clarifying the current understanding of VD’s regulatory functions in the TME of BC. The pivotal anti-cancer functions of VD comprise a spectrum of activities, influencing cell cycle regulation, chemoprotection, differentiation, apoptosis, proliferation, angiogenesis, as well as having anti-metastatic and anti-invasive properties. In this review, we comprehensively outline VD’s anti-cancer mechanisms within the context of the BC TME, meticulously detailing its regulatory impact on cancer-associated fibroblasts, adipocytes, immune cells, cancer stem cells, and the extracellular matrix.

This unique perspective highlights the potential of using VD to re-program the TME and enhance the efficacy of current BC therapeutics.

Authors’ abstract

Simple Summary

Breast cancer (BC) develops within a complex tumor microenvironment (TME) consisting of cancer-associated fibroblasts, adipocytes, immune cells, cancer stem cells, and the extracellular matrix, all of which play a crucial role in tumor progression and metastasis. Vitamin D (VD) is widely recognized for its protective effects against BC, due to its ability to regulate the cell cycle, promote apoptosis, inhibit angiogenesis, and suppress metastasis. While the anti-cancer properties of VD have been extensively studied, its specific role within the BC TME remains underexplored.

This review highlights VD’s regulatory influence on various TME components, underscoring its potential to reshape the TME and enhance BC treatment strategies.

Abstract

The intricate and diverse TME within breast cancer (BC) comprises a complex amalgamation of cell populations, encompassing immune cells, cancer-associated fibroblasts, cancer stem cells and the extracellular matrix. These constituents have profound influence over tumor progression and metastasis. Vitamin D (VD) is increasingly recognized as a multifunctional hormone, with strong clinical and epidemiological evidence supporting its protective role against cancer, particularly BC. Although its anti-neoplastic effects in BC have been widely studied, few investigations have thoroughly explored its influence within the tumor microenvironment (TME).

This review seeks to address that gap by clarifying the current understanding of VD’s regulatory functions in the TME of BC. The pivotal anti-cancer functions of VD comprise a spectrum of activities, influencing cell cycle regulation, chemoprotection, differentiation, apoptosis, proliferation, angiogenesis, as well as having anti-metastatic and anti-invasive properties. In this review, we comprehensively outline VD’s anti-cancer mechanisms within the context of the BC TME, meticulously detailing its regulatory impact on cancer-associated fibroblasts, adipocytes, immune cells, cancer stem cells, and the extracellular matrix.

This unique perspective highlights the potential of using VD to re-program the TME and enhance the efficacy of current BC therapeutics.

Publication and source details

Original title: The Effects of Vitamin D on the Breast Cancer Tumor Microenvironment

Balquees Kanwal; Syeda Saba Shah; Farzana Shaheen; Mekonnen Sisay Shiferaw; Deepanshu Maurya; Yujie Li; Saranya Pounraj; Zaklina Kovacevic

Cancers · 2025

* Correspondence: z.kovacevic@unsw.edu.au© 2025 by the authors.2025https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).This research received no external funding.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T23:27:04.476897+00:00

DOI: 10.3390/cancers17233751 · PMC12691352